Genomic Valley Biotech Limited has announced the publication of its financial results for the quarter and nine months ended 31st December 2025. The company shared these results via newspaper advertisements, making the key financial data accessible to all stakeholders. This update is important for investors to assess GVBL's recent performance and understand its operational trajectory over the last three and nine months, which is vital for informed investment analysis.